target
rnai
screen
perform
identifi
human
ddx
protein
involv
iav
multipl
small
interf
rna
target
ddx
protein
tabl
transfect
cell
sirna
target
b
form
use
alon
combin
sirna
known
inhibit
iav
use
control
toxic
sirna
treatment
silenc
effici
evalu
describ
method
section
reduct
cell
viabil
signal
measur
compar
control
sirnatr
cell
except
cell
silenc
b
b
figur
effici
silenc
decreas
protein
express
signal
achiev
ddx
protein
except
decreas
figur
cell
transfect
nontox
sirna
subsequ
infect
low
multipl
infect
moi
recombin
viru
carri
luciferas
report
gene
luciferas
activ
measur
cell
lysat
prepar
hour
postinfect
hpi
monitor
effici
viral
replic
shown
fig
iav
replic
significantli
impair
upon
silenc
ddx
protein
among
ddx
protein
previous
found
posit
regul
iav
replic
recov
screen
possibl
due
low
knockdown
effici
figur
silenc
shown
other
neg
regul
iav
signific
effect
screen
upon
cosilenc
b
form
ident
protein
level
reduct
luciferas
signal
significantli
greater
upon
silenc
alon
reduct
compar
respect
fig
indic
synergist
effect
deplet
repeat
experi
three
individu
sirna
target
conserv
region
fig
c
strong
reduct
luciferas
signal
observ
three
individu
sirna
fig
thu
rule
offtarget
effect
experi
describ
combin
sirna
thereaft
name
sirna
use
effect
knockdown
multipl
sever
wildtyp
iav
examin
cell
treat
control
sirna
infect
low
moi
product
infecti
viral
particl
evalu
hpi
wsn
fig
hpi
strain
fig
time
point
wsn
viru
titer
supernat
cell
decreas
log
compar
control
cell
fig
hpi
similar
reduct
observ
upon
infect
virus
fig
reduct
observ
vsv
indiana
strain
fig
negativestrand
rna
viru
rhabdovirida
famili
replic
cytoplasm
contrast
product
infecti
adenoviru
doublestrand
dna
viru
adenovirida
famili
decreas
upon
deplet
fig
result
confirm
essenti
iav
multipl
suggest
potenti
implic
life
cycl
virus
replic
nucleu
document
role
iav
multipl
tempor
accumul
viral
compon
analyz
cell
singlecycl
infect
wsn
shown
fig
control
cell
accumul
ha
na
np
viral
protein
detect
hpi
cell
accumul
viral
protein
longer
ha
na
weakli
np
detect
hpi
strongli
reduc
hpi
compar
control
cell
monitor
np
na
vrna
mrna
use
strandspecif
show
mrna
level
reduc
hpi
cell
compar
control
cell
np
na
averag
signific
differ
observ
later
time
point
except
na
mrna
hpi
fig
c
effect
accumul
np
na
vrna
delay
vrna
level
strongli
reduc
hpi
still
hpi
np
na
hpi
respect
fig
e
hypothes
mrna
level
appear
less
affect
hpi
accumul
plateau
time
point
unlik
viral
vrna
continu
accumul
high
rate
notabl
vrna
mrna
speci
examin
level
measur
cell
hpi
similar
level
measur
control
cell
hpi
respect
taken
togeth
data
indic
silenc
distinctli
affect
process
transcriptionrepl
per
se
delay
accumul
viral
rna
earli
time
point
infect
disrupt
whole
viral
cycl
test
whether
nuclear
import
parent
vrna
affect
silenc
cell
treat
cycloheximid
chx
infect
inhibit
de
novo
viral
protein
express
incom
vrna
monitor
subcellular
fraction
shown
fig
viral
protein
accumul
detect
hpi
presenc
chx
demonstr
effici
chx
treatment
qualiti
subcellular
fraction
control
experi
immunoblot
use
antibodi
kinas
cytoplasm
marker
tata
bind
protein
tbp
nuclear
marker
addit
level
gapdh
premrna
evalu
realtim
rtpcr
use
nuclear
marker
repres
data
shown
fig
qualiti
subcellular
fraction
affect
viral
infect
fig
strandspecif
rtqpcr
use
monitor
level
np
na
vrna
cytoplasm
nuclear
fraction
chxtreat
cell
well
level
primari
transcript
incom
vrna
templat
proport
nuclear
vrna
similar
control
cell
fig
thu
indic
nuclear
import
parent
vrna
impair
shown
fig
mrnavrna
ratio
reduc
silenc
chxtreat
cell
howev
differ
statist
signific
indic
limit
effect
primari
transcript
altogeth
result
demonstr
critic
function
earliest
step
influenza
viral
cycl
next
examin
potenti
role
export
viral
mrna
end
sirnatr
cell
infect
subject
subcellular
fraction
hpi
level
cytoplasm
nuclear
np
na
mrna
determin
rtqpcr
fig
b
hpi
control
cell
substanti
proport
mrna
speci
found
cytoplasm
fig
dark
grey
solid
bar
cell
proport
cytoplasm
viral
mrna
strikingli
reduc
fig
light
grey
solid
bar
sensit
rtqpcr
insuffici
evalu
accur
level
cytoplasm
nuclear
mrna
hpi
hpi
control
cell
viral
mrna
appear
equal
distribut
fraction
np
na
predominantli
cytoplasm
mrna
fig
contrast
cell
viral
mrna
remain
predominantli
nuclear
viral
mrna
detect
cytoplasm
fig
although
differ
repeatedli
observ
n
effect
silenc
hpi
gener
signific
upon
statist
analysi
function
homolog
yeast
extens
studi
mutant
defect
rna
bind
atpas
activ
bind
show
strong
defect
nuclear
export
mrna
confirm
activ
contribut
function
iav
replic
perform
rnai
rescu
experi
fig
upon
silenc
cell
sirnaresist
express
plasmid
wildtyp
mutant
protein
transfect
express
level
differ
mutant
protein
differ
significantli
fig
publish
data
indic
properli
effici
viral
replic
assess
use
viru
fig
wildtyp
plasmid
dark
grey
bar
could
rescu
level
viral
replic
appar
contradict
fact
upon
deplet
appear
play
role
viral
infect
fig
like
due
high
express
level
recombin
protein
unlik
wildtyp
plasmid
dark
grey
bar
none
mutant
plasmid
test
light
grey
bar
rescu
level
viral
replic
thu
activ
relat
function
nuclear
export
mrna
appear
requir
iav
replic
taken
togeth
nuclear
retent
viral
mrna
deplet
cell
data
clearli
establish
essenti
contribut
nuclear
export
iav
mrna
previous
report
interact
viral
polymeras
infecti
context
use
gaussia
luciferas
complement
assay
name
ipca
infecti
protein
complement
assay
system
recombin
wsn
viru
encod
polymeras
subunit
use
infect
cell
transient
express
protein
interest
fuse
signific
luciferas
activ
restor
brought
close
proxim
interact
confirm
interact
endogen
protein
viral
polymeras
infect
assess
whether
interact
requir
presenc
rna
immunoprecipit
lysat
cell
infect
recombin
wsn
viru
express
streptag
protein
presenc
absenc
rnase
fig
upon
immunoprecipit
fig
upper
panel
protein
specif
coimmunoprecipit
condit
rna
integr
preserv
fig
middl
panel
rnase
fig
middl
panel
rnase
rna
cell
lysat
eluat
extract
viral
np
mrna
vrna
quantifi
strandspecif
rtqpcr
could
detect
rnasetr
sampl
data
shown
thu
demonstr
effici
rnase
treatment
rnasefre
sampl
higher
proport
np
mrna
coimmunoprecipit
copi
input
np
mrna
compar
np
vrna
copi
input
np
vrna
p
fig
confirm
specif
viral
mrna
associ
determin
effici
copurifi
recombin
streptag
wildtyp
protein
rnabind
atpas
defect
mutant
counterpart
mutant
fig
streptag
protein
use
posit
control
shown
bind
iav
upon
transient
express
cell
subsequ
infect
wsn
viru
streptag
protein
purifi
fig
np
na
mrna
quantifi
rtqpcr
rna
extract
cell
lysat
c
eluat
e
fraction
ec
ratio
mrna
level
determin
protein
normal
obtain
mutant
protein
shown
fig
np
na
mrna
enrich
upon
copurif
protein
respect
compar
mutant
protein
dissect
connect
interact
use
ipca
assess
capac
mutant
protein
interact
fig
cell
transient
express
wildtyp
mutant
protein
subsequ
infect
viru
mutant
fuse
express
similar
level
fig
shown
fig
similar
interact
signal
observ
mutant
defect
rna
bind
wildtyp
protein
result
agreement
coimmunoprecipit
data
show
interact
rnaindepend
fig
interestingli
presenc
mutant
signific
increas
interact
signal
observ
compar
wildtyp
doublemut
protein
fig
mutant
shown
defici
atpas
activ
unlik
doublemut
retain
strong
rna
bind
data
show
properti
result
stabil
interact
altogeth
result
demonstr
rnaindepend
associ
viral
polymeras
modul
atpas
activ
provid
first
target
rnai
screen
dexdbox
rna
helicas
famili
largest
divers
group
human
rna
helicas
identifi
requir
effici
iav
replic
hit
rnai
screen
includ
addit
found
previous
promot
iav
new
cellular
factor
potenti
involv
iav
replic
ie
dramat
decreas
iav
replic
observ
upon
silenc
therefor
analyz
detail
role
ddx
hit
remain
investig
given
multifunct
natur
ddx
protein
could
potenti
involv
variou
step
viral
cycl
recogn
function
includ
splice
premrna
mrna
export
protein
translat
exosomemedi
rna
decay
also
name
ribosom
mitoribosom
biogenesi
modul
signal
pathway
studi
reveal
cellular
protein
play
essenti
role
iav
infect
mediat
viral
mrna
export
assum
regulatori
mechan
describ
yeast
homolog
conserv
human
mrnp
remodel
activ
depend
rna
bind
activ
well
bind
atpas
consist
observ
deplet
inhibit
nuclear
export
iav
mrna
fig
ii
lead
reduct
viral
replic
rescu
reexpress
wildtyp
protein
mutant
defect
rna
bind
bind
atpas
activ
fig
effect
deplet
nucleocytoplasm
distribut
viral
mrna
detect
hpi
lesser
extent
hpi
fig
b
suggest
requir
bypass
viral
infect
proce
accumul
high
level
viral
mrna
nucleu
andor
virusinduc
modif
cellular
environ
eg
alter
permeabl
nuclear
could
allow
viral
mrna
export
nucleu
independ
still
cell
inhibit
viral
mrna
export
earli
time
point
result
consider
delay
viral
life
cycl
impair
product
viral
rna
viral
protein
fig
strongli
reduc
product
infecti
viru
particl
observ
sever
iav
strain
fig
possibl
role
life
cycl
virus
replic
nucleu
adenovirus
fig
deserv
explor
major
player
involv
iav
mrna
export
far
nuclear
export
factor
also
known
suggest
intronless
unsplic
splice
viral
mrna
may
harbor
differenti
depend
andor
use
distinct
adaptor
recruit
three
type
viral
mrna
includ
studi
found
depend
nuclear
export
fig
associ
specif
infect
cell
fig
base
avail
structur
data
seem
bind
rna
non
sequencespecif
manner
contact
made
sugarphosph
unknown
whether
small
rna
microrna
trna
mrnp
transport
reli
nuclear
also
unclear
whether
mrnp
transport
undergo
remodel
whether
direct
specif
mrnp
adaptor
protein
knowledg
document
case
adaptor
protein
bind
could
specif
target
histon
use
ipca
fig
ref
coimmunoprecipit
assay
fig
demonstr
physic
interact
viral
polymeras
context
infect
cell
show
interact
rnaindepend
fig
howev
viral
mrna
copurifi
complex
fig
b
suggest
recruit
viral
mrna
interact
viral
polymeras
interestingli
interact
signal
higher
presenc
mutant
abl
bind
rna
defici
atpas
presum
compromis
abil
remodel
export
mrnp
dissoci
rnabind
protein
compon
fig
observ
suggest
complex
transient
viral
polymeras
dissoci
upon
atp
hydrolysisdriven
remodel
viral
mrnp
line
previou
report
viral
mrna
stabli
associ
viral
polymeras
infect
model
propos
coupl
atpas
cycl
export
cellular
mrnp
mostli
base
vitro
studi
may
accur
reproduc
complex
mrnp
substrat
spatial
organ
one
model
propos
nucleoporin
ensur
load
onto
mrnp
cytoplasm
face
npc
atp
hydrolysisdriven
remodel
mrnp
second
model
propos
mrnp
initi
bound
remodel
upon
atp
hydrolysi
stimul
releas
mrnp
cellulo
observ
clearli
favor
second
model
also
support
exist
intranuclear
pool
associ
mrnp
cellular
transcript
bind
iav
polymeras
ctermin
domain
cellular
rna
polymeras
ii
earli
might
facilit
associ
thu
load
possibl
cotranscript
onto
viral
mrnp
overal
studi
identifi
set
divers
intronless
unsplic
splice
target
mrna
shed
light
direct
mrna
final
point
iav
infect
use
model
elucid
mechan
dynam
mrnp
remodel
nuclear
export
human
cell
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
mdck
cell
grown
modifi
eagl
medium
mem
supplement
fc
cycloheximid
chx
sigma
ad
medium
time
infect
influenza
virus
provid
nation
influenza
center
institut
pasteur
pari
franc
virus
produc
revers
genet
describ
ref
vsv
indiana
strain
viru
kindli
provid
delma
institut
pasteur
pari
franc
adenoviru
kindli
provid
p
fort
universidad
de
navarra
pamplona
spain
recombin
virus
express
protein
fuse
streptag
describ
recombin
viru
express
nanoluc
protein
produc
revers
genet
use
plasmid
describ
gateway
entri
plasmid
contain
ddx
orf
obtain
human
orfeom
resourc
gener
vector
encod
glucfl
strepddx
fusion
protein
orf
transfer
respect
gatewaycompat
pglucfl
destin
plasmid
kindli
provid
c
demeret
jacob
respect
direct
mutagenesi
gateway
entri
plasmid
perform
use
quikchang
ii
sitedirect
mutagenesi
kit
agil
sirna
resist
cdna
design
silico
produc
genscript
revers
genet
plasmid
produc
replac
sequenc
sequenc
encod
selfcleav
peptid
porcin
teschoviru
follow
nanoluc
code
sequenc
describ
ref
nanoluc
templat
kindli
provid
p
pales
n
heaton
icahn
school
medicin
mount
sinai
new
york
usa
construct
verifi
sanger
sequenc
sequenc
oligonucleotid
use
amplif
sequenc
provid
upon
request
unless
otherwis
note
protein
extract
prepar
laemmli
buffer
immunoblot
membran
incub
primari
antibodi
direct
novu
biolog
kindli
provid
daniel
marc
inratour
franc
pierc
ha
genetex
na
genetex
gapdh
pierc
tpb
cell
signal
cell
signal
gaussia
luciferas
new
england
biolab
reveal
secondari
antibodi
ge
healthcar
peroxidaseconjug
streptactin
iba
ecl
substrat
pierc
chemiluminesc
signal
acquir
use
gbox
genesnap
softwar
syngen
small
interf
rna
sirna
purchas
dharmacon
ontargetplu
smartpool
individu
sirna
nontarget
control
pool
cell
transfect
nm
sirna
use
transfect
reagent
dharmacon
cell
viabil
determin
use
celltiterglo
luminesc
viabil
assay
kit
promega
control
effici
sirna
target
ddxn
gene
sirnatr
cell
transfect
plasmid
encod
ddxn
protein
fuse
fulllength
gaussia
luciferas
pglucflddxn
use
polyethylenimin
pei
polysci
inc
luciferas
activ
measur
h
later
cell
lysat
use
renilla
luciferas
assay
reagent
promega
berthold
centrox
luminomet
screen
purpos
cell
infect
hpt
viru
moi
pfucel
rescu
experi
cell
transfect
nm
combin
sirna
use
interferin
reagent
polyplu
empti
vector
use
fugen
reagent
promega
cell
infect
hpt
viru
moi
pfucel
luciferas
activ
measur
hpi
use
nanoluc
luciferas
kit
promega
multicycl
singlecycl
infect
assay
cell
infect
hpt
low
high
moi
respect
describ
ref
plaqu
assay
mdck
cell
perform
describ
ref
adv
titrat
immunostain
describ
ref
cell
pellet
g
min
wash
three
time
cold
pb
cell
pellet
resuspend
lysi
buffer
mm
hepe
ph
mm
mm
kcl
mm
dtt
igep
incub
min
ice
nuclei
pellet
centrifug
g
min
supernat
save
cytoplasm
fraction
nuclear
pellet
resuspend
low
salt
buffer
mm
hepe
ph
mm
mm
kcl
mm
dtt
mm
edta
glycerol
high
salt
buffer
mm
hepe
ph
mm
kcl
mm
dtt
mm
edta
glycerol
ad
incub
spin
wheel
min
insolubl
nuclear
fraction
pellet
g
min
supernat
save
nuclear
fraction
cytoplasm
nuclear
rna
extract
use
sequenti
trizol
ls
invitrogen
rneasi
mini
kit
qiagen
unless
otherwis
note
rna
extract
use
rneasi
mini
kit
qiagen
strandspecif
rtqpcr
np
na
vrna
mrna
perform
describ
ref
altern
poli
rna
isol
use
dynabead
mrna
purif
kit
life
technolog
revers
transcript
perform
use
maxima
first
strand
cdna
synthesi
kit
thermo
scientif
follow
qpcr
use
sybr
green
reagent
roch
solari
qpcr
express
assay
reagent
life
technolog
light
cycler
roch
gapdh
transcript
primer
probe
provid
thermo
scientif
primer
use
np
na
transcript
describ
plasmid
contain
sequenc
interest
use
calibr
curv
absolut
quantif
primer
gapdh
premrna
provid
upon
request
infect
resuspend
lysi
buffer
mm
mopskoh
ph
mm
kcl
igep
proteas
inhibitor
cocktail
roch
supplement
uml
rnasin
promega
rnase
thermo
scientif
clarifi
lysat
incub
igg
control
igg
hour
immunocomplex
purifi
protein
coupl
bead
thermo
scientif
wash
lysi
buffer
elut
perform
use
laemmli
buffer
protein
analys
rlt
buffer
rneasi
mini
kit
qiagen
rna
analys
streptag
protein
interest
purifi
use
streptactin
bead
describ
ref
infecti
protein
complement
assay
cell
transfect
plasmid
subsequ
infect
recombin
wsn
viru
express
polymeras
subunit
fuse
describ
ref
normal
luminesc
ratio
nlr
determin
describ
cite
articl
diot
c
et
al
influenza
viru
polymeras
recruit
rna
helicas
promot
nuclear
export
viral
mrna
sci
rep
doi
